Hosted on MSN9mon
Multibagger stock: Lupin shares rally after Kotak's double upgrade on pharma playerShares of Lupin surged more than 5.22 per cent to Rs ... there has not been any impact of the ceiling on OOP costs for inhalers on gSpiriva’s pricing and market share as yet," Kotak said.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback